WMT AG

Private

HeidelbergHealthcare & Life Scienceshttps://www.wm-therapeutics.com/

Last Round

VC Round

Oct 14, 2025

Total Funding Raised

$2.22M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

WMT AG is a biotechnology company that develops small molecule therapeutics for the treatment of cancer and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

small molecule drug discoverydrug discovery platformpre-clinical biotechTranslational Trapprotein translation inhibitiononcology drug candidatescancer therapyautoimmune disease therapyinflammatory disease therapyantiviral drugsselective cell inhibitiondrug licensingbiopharma asset salesB-cell cancerssepsis treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

WMT AG Comps

Public and private peers based on sector, stage, and business model.

WMT AG comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

WMT AG Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Oct 14, 2025
VC Round	Jan 23, 2025
VC Round	Nov 28, 2023

View all Funding Rounds

WMT AG Investors

Notable investors and investment history

WMT AG investors
Investor	Rounds
FS Life Science Investment	VC Round
Viva Biotech	Seed
Marathon Beteiligungs AG	VC Round
CARMA FUND	VC Round
High-Tech Gründerfonds	VC Round, Seed
L-Bank	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 15, 2025
Grew 21% QoQ from 14 to 17 employees.
Oct 14, 2025
$4.25M round led by Marathon Beteiligungs AG

View all signals

WMT AG Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

WMT AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about WMT AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersHeidelberg

Employee Range17

Year Founded2020

Last FundingOct 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.